Pharmacotherapy Publishing Inc
View my basket
Atypon Link logo

You have no access to this article

Clinical Impact of a Pharmacist-Managed Diabetes Mellitus Drug Therapy Management Service


Author(s): Amie D McCord
doi: 10.1592/phco.26.2.248
Prev | Table of contents | Next
 
View PDF article (69 K) View references
Email this link
 What is RSS?
Trouble viewing articles as PDF?
 
  Pharmacotherapy
 
Print ISSN: 0277-0008
Volume: 26 | Issue: 2
Cover date: February 2006
Page(s): 248-253
 
 
  Key Words
 
disease management, diabetes mellitus, clinical pharmacy, drug therapy management
 
  Abstract

Study Objective. To evaluate the impact of clinical pharmacist interventions, including drug therapy management, on outcomes relevant to diabetes mellitus.

Design. Retrospective chart review.

SettingAmbulatory, multispecialty physician group practice within a managed care environment in suburban Chicago, Illinois.

Patients. Three hundred sixteen patients aged 18 years or older, with a diagnosis of diabetes mellitus (89% with type 2), who were referred to a clinical pharmacy service.

Intervention. Drug therapy management and education service provided by a clinical pharmacist.

Measurements and Main Results. Data were collected for glycosylated hemoglobin A1c (A1C), blood pressure, and low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol (HDL), and triglyceride concentrations. Data also were collected regarding patient adherence with American Diabetes Association guidelines for preventive care, including annual eye and foot examinations, influenza shots, and daily aspirin use at both baseline and follow-up. Mean ± SD A1C reduction was 1.4% ± 1.94% (p<0.001); the percentage of patients whose A1C was at goal level at baseline (< 7%) increased from 14.8% to 43.2% (p<0.001). Mean ± SD LDL level reduction was 14 ± 41.1 mg/dl (p=0.002), mean ± SD triglyceride level reduction 42 ± 97.6 mg/dl (p<0.001). The percentage of patients who reached goal for LDL level (< 100 mg /dl), HDL level (> 40 mg/dl), and blood pressure (< 130/80 mm Hg) did not increase significantly from baseline, whereas those who reached the triglyceride level goal (< 150 mg/dl) increased from 36% to 55% (p<0.005). Frequency of annual dilated retinal examinations and monofilament foot examinations increased by 29% (p<0.05) and 12.5% (p<0.05), respectively. Daily aspirin use increased from 35% to 59% (p<0.05).

Conclusion. Significant clinical improvement occurred in patients referred to the pharmacist in a diabetes drug therapy management program.

 
  Author(s) affiliations
 
1From the Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois.
1Address reprint requests to Amie D. McCord, Pharm.D., BCPS, CDE, Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, 555 31st Street, Downers Grove, IL 60515-1235
 
  This article has been cited by:
1.
 
Control of modifiable risk factors in ischemic stroke outpatients by pharmacist intervention: an equal allocation stratified randomized study.
Chun-Chi Chiu, Shin-Sheng Wu, Ping-Yi Lee, Yu-Ching Huang, Teng-Yeow Tan, Ku-Chou Chang.
Journal of Clinical Pharmacy and Therapeutics |  33 |  5 |  529-535
CrossRef